THC cannabis concentrate

What would data-driven policy suggest regarding THC cannabis concentrate caps in Vermont and Quebec?

The recent article on THC limits in cannabis concentrates leaves out the important fact that Vermont law currently includes a 60% cap on THC in solid concentrates. Thankfully, lawmakers in the Vermont House have listened to the science, and they are working to keep the high THC concentrates cap in H.548. The intent of Act 164 as passed and as sold to Vermonters is that the commercial sale of cannabis is “for the purpose of public health and safety.”

What is new is the Cannabis Control Board’s push for these dangerous products before the market in Vermont is even off the ground. These are not products used by the “casual” cannabis consumer. In the 1990s, the average THC content in marijuana flower was less than 4%. It is now about 15% — and we’re talking about products with a potency of up to 80 or 90% THC.

Read the full opinion piece by IASIC Treasurer Catherine Antley published in the Rutland Herald here: https://www.rutlandherald.com/opinion/commentary/antley-thc-cannabis-concentrate/article_29a84df6-ccb8-57f3-9f4e-4fc3276062fb.html

For more information on the International Academy on the Science and Impact of Cannabis, and to join, please visit www.IASIC1.org.

Visit the IASIC Library here (https://iasic1.org/library/). The IASIC Library is intended as a user-friendly reference of the published medical literature.

Like this article?

Share on Facebook
Share on Twitter
Share on Linkdin
Share on Pinterest

Related Posts

IASIC Speaker Series Presents: Impacts of Maternal Cannabis Use on Long-Term Psychiatric Risk

The International Academy on the Science and Impact of Cannabis (IASIC) is excited to present the IASIC Speaker Series. Presented free of charge, this ongoing educational seminar series will focus on the science, data and peer-reviewed research surrounding marijuana and will be led by international medical experts. This non-partisan and non-political series is continually developed,

Libby Stuyt Interview on Randy Tobler show

Exciting News! Libby Stuyt’s Interview on Randy Tobler Show! Hey everyone, we wanted to share some thrilling news! The brilliant Dr. Libby Stuyt recently had an enlightening interview on Randy Tobler Show. Dr. Stuyt is known for her groundbreaking work in the field of addiction medicine and mental health. Her insights are nothing short of

Balancing risks and benefits of cannabis use: umbrella review of meta-analyses of randomised controlled trials and observational studies

Introduction Cannabis contains over 100 cannabinoids, of which Δ9-tetrahydrocannabinol and cannabidiol are the most clinically relevant. Tetrahydrocannabinol is a partial agonist at CB1 and binds CB2 receptors. CB1 is widely expressed by central and peripheral neurones but also by immune cells and other type of cells in the brain and in the periphery, and when

Medical marijuana access and prolonged opioid use among adolescents and young adults

Abstract Background and Objectives Laws liberalizing access to medical marijuana are associated with reduced opioid analgesic use among adults, but little is known about the impact of such policies on adolescents and young adults. Methods This retrospective cohort study used 2005 to 2014 claims from MarketScan® Commercial database, which covers all 50 states and Washington

Scroll to Top